Suppr超能文献

确定氨基酸基共无定形系统中的最佳摩尔比。

Determination of the Optimal Molar Ratio in Amino Acid-Based Coamorphous Systems.

机构信息

Department of Pharmacy, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark.

出版信息

Mol Pharm. 2020 Apr 6;17(4):1335-1342. doi: 10.1021/acs.molpharmaceut.0c00042. Epub 2020 Mar 9.

Abstract

Coamorphous drug formulations are a promising approach to improve solubility and bioavailability of poorly water-soluble drugs. On the basis of theoretical assumptions involving molecular interactions, the 1:1 molar ratio of drug and coformer is frequently used as "the optimal ratio" for a homogeneous coamorphous system (i.e., the coamorphous system with the highest physical stability and, if strong interaction is possible between two molecules, the highest glass transition temperature ()). In order to more closely investigate this assumption, l-aspartic acid (ASP) and l-glutamic acid (GLU) were investigated as coformers for the basic drug carvedilol (CAR) at varying molar ratios. Salt formation between CAR with ASP or GLU was expected to occur at the molar 1:1 ratio based on their chemical structures. Interestingly, the largest deviation between the experimental and the theoretical based on the Gordon-Taylor equation was observed at a molar ratio of around 1:1.5 in CAR-ASP and CAR-GLU systems. In order to determine the exact value of the ratio with the highest , a data fitting approach was established on thermometric data of various CAR-ASP and CAR-GLU systems. The highest was found to be at CAR-ASP 1:1.46 and CAR-GLU 1:1.43 mathematically. Spectroscopic investigations and physical stability measurements further confirmed that the optimal molar ratio for obtaining a homogeneous system and the highest stability can be found at a molar ratio around 1:1.5. Overall, this study developed a novel approach to determine the optimal ratio between drug and coformers and revealed the influence of varying molar ratios on molecular interactions and physical stability in coamorphous systems.

摘要

共晶药物制剂是提高难溶性药物溶解度和生物利用度的一种有前途的方法。基于涉及分子相互作用的理论假设,药物和共晶形成剂的 1:1 摩尔比经常被用作均相共晶体系的“最佳比例”(即具有最高物理稳定性的共晶体系,如果两个分子之间可能存在强相互作用,则具有最高玻璃化转变温度 (T g ))。为了更仔细地研究这一假设,研究了 L-天冬氨酸(ASP)和 L-谷氨酸(GLU)作为碱性药物卡维地洛(CAR)的共晶形成剂,摩尔比不同。基于它们的化学结构,预计 CAR 与 ASP 或 GLU 之间会形成盐。有趣的是,在 CAR-ASP 和 CAR-GLU 体系中,观察到实验 值与基于 Gordon-Taylor 方程的理论 值之间的最大偏差约为 1:1.5。为了确定 值最高的比例的确切值,建立了一个针对各种 CAR-ASP 和 CAR-GLU 体系的热测量数据拟合方法。发现 值最高的比例为 CAR-ASP 1:1.46 和 CAR-GLU 1:1.43。光谱研究和物理稳定性测量进一步证实,获得均相体系和最高稳定性的最佳摩尔比可以在 1:1.5 左右找到。总的来说,这项研究开发了一种确定药物和共晶形成剂之间最佳比例的新方法,并揭示了不同摩尔比对共晶体系中分子相互作用和物理稳定性的影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验